Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-25-046110
Filing Date
2025-05-08
Accepted
2025-05-08 16:10:06
Documents
17
Effectiveness Date
2025-05-08

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2514102d1_s8.htm S-8 27459
2 EXHIBIT 5.1 tm2514102d1_ex5-1.htm EX-5.1 10416
3 EXHIBIT 23.1 tm2514102d1_ex23-1.htm EX-23.1 1985
4 EX-FILING FEES tm2514102d1_ex-filingfees.htm   iXBRL EX-FILING FEES 12590
5 GRAPHIC tm2514102d1_ex5-img001.jpg GRAPHIC 2933
6 GRAPHIC tm2514102d1_ex5-1img002.jpg GRAPHIC 1850
  Complete submission text file 0001104659-25-046110.txt   186407

Data Files

Seq Description Document Type Size
19 EXTRACTED XBRL INSTANCE DOCUMENT tm2514102d1_ex-filingfees_htm.xml XML 4602
Mailing Address 64 SIDNEY ST. CAMBRIDGE MA 02139
Business Address 64 SIDNEY ST. CAMBRIDGE MA 02139 7349305555
Vericel Corp (Filer) CIK: 0000887359 (see all company filings)

EIN.: 943096597 | State of Incorp.: MI | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-287079 | Film No.: 25926126
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)